# FDA Inspection 986827 - NYU Langone Health Institutional Review Board - September 15, 2016

Source: https://www.keypedia.com/records/fda_inspections/nyu-langone-health-institutional-review-board/3fcb6aff-eb34-4bb8-ab35-e50f6e470f24
Source feed: FDA_Inspections

> FDA Inspection 986827 for NYU Langone Health Institutional Review Board on September 15, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 986827
- Company Name: NYU Langone Health Institutional Review Board
- Inspection Date: 2016-09-15
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 936460 - 2015-07-22](https://www.keypedia.com/records/fda_inspections/nyu-langone-health-institutional-review-board/0fb1da0c-5e04-4e8a-96c1-625e95b04c44)
- [FDA Inspection 736685 - 2011-07-15](https://www.keypedia.com/records/fda_inspections/nyu-langone-health-institutional-review-board/321c476d-5b84-437f-9871-be5e32eeb406)

Company: https://www.keypedia.com/companies/nyu-langone-health-institutional-review-board/8f02a5ab-f35f-4c0c-ab65-42cac52a0774

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c